Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine
Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Location: United States, FL
Have you been diagnosed with COPD? We are seeking participants who are currently taking Advair or Symbicort on a daily basis to evaluate an investigational medication for COPD
We are currently participating in a study to demonstrate the additional benefit of a FDA Approved Oral Medication when added on to fixed-dose combination of Advair or Symbicort in the reduction of exacerbations in subjects with severe to very severe COPD
Patient Inclusion Criteria:
Patient Exclusion Criteria:
COPD exacerbation and/or COPD exacerbations treated with antibiotics or systemic glucocorticosteroids within 4 weeks of
Known alpha-1-antitrypsin deficiency
Current diagnosis of asthma (either controlled or uncontrolled)
Body mass index (BMI) ≥ 45
Participants will receive study-related care and medications at no cost.
Compensation may be available for time and travel
CW ID: 180207
Date Last Changed:
July 19, 2013
Luis A. Sanchez, Study CoordinatorCentral Medical Group, P.A Research6610 N. University Drive
Suite 120Tamarac, FL 33321Phone: 954-720-7211
Research Center Information: Central Medical Group, P.A Research
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.